MissionIR Articles
-
MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Releases Q3 2023 Financial Results
D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services, is reporting its numbers for the third quarter of 2023. Highlights of the report included revenue of $2.6 million for the quarter,…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Expansion of US Battery Operations
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced a new high-energy facility in Fullerton, California, which expands the company’s overall U.S. footprint, including EV battery development and production capabilities. According to…
-
MissionIRNewsBreaks — Longeveron Inc. (NASDAQ: LGVN; LGVNR) Study Survival Data Reported at AHA’s 2023 Scientific Sessions
Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (HLHS), Alzheimer’s disease and Aging-Related Frailty, is reporting on data from a long-term…
-
Diamond Lake Minerals Inc. (DLMI) Bridges Gap Between Old-school Business Models, New-school Digital Assets
Multi-strategy operating company Diamond Lake Minerals (OTC: DLMI) is building a digital vision for the future on a foundation that includes decades of experience in diverse market sectors, as represented by the company’s new executive team. The…
-
SenesTech Inc. (NASDAQ: SNES) Begins Taking Orders for their new Soft Bait Rodent Contraceptive That Provides Unique Approach to Pest Control
With the advent of cooler weather in the Northern Hemisphere, rodents become more noticeable in homes and buildings as they seek warmer refuge. Pest control giant Orkin estimates mice and other rodents invade around 21…
-
MissionIRNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Announces 2023 Results, Provides Corporate Update
Longeveron (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, today announced its results for the quarter ended Sept. 30, 2023, and provided a corporate update. “During our third quarter…
-
MissionIRNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Announces Q3 2023 Results
Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, has announced business updates and financial results for the third quarter ended Sept. 30, 2023. Among the highlights, the company reported $3.8…
-
MissionIRNewsBreaks — SenesTech Inc. (NASDAQ: SNES) Reports on Q3 2023 Financial Results, Business Update
SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, is reporting its third-quarter 2023 financial results and key achievements. According to the report, revenue growth increased 44% for the company compared…
-
Clene Inc. (NASDAQ: CLNN) Among Grant Awardees Selected to Advance Scientific Research on ALS
In late December of 2021, President Biden signed into law H.R. 3537, the Accelerated Access to Critical Therapies for ALS Act (“Act for ALS”) (https://ibn.fm/oQbSk). The Act for ALS (amyotrophic lateral sclerosis), now public law, directs the…
-
Renovaro Biosciences Inc. (NASDAQ: RENB) CEO Provides Update on Combination with AI Expert GEDiCube Intl Ltd. in Letter to Shareholders
In September, Renovaro Biosciences (NASDAQ: RENB), an advanced, preclinical biotechnology company focused on cell, gene, and immunotherapy, and GEDiCube Intl Ltd., an AI medical technology company, announced a definitive agreement for combination. Under the stock-for-stock agreement,…
-
MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Expands Scientific Advisory Board as It Advances Product Development, Clinical and Commercial Efforts
HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only credit card-size 3D-vector electrocardiogram (“VECG”) platform for patient use at home, today announced the expansion of its scientific advisory board (“SAB”)…
-
MissionIRNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) CMO Featured in Latest Bell2Bell Podcast Release
PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, is in the spotlight during a recent episode of The Bell2Bell podcast. During the podcast, PaxMedica chief medical officer David Hough and…
-
Freight Technologies Inc. (NASDAQ: FRGT) Secures Request for Quotation with Global Pharmaceutical Conglomerate for Secure Product Transport
Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a technology company developing solutions to optimize and automate the supply chain process through its custom-developed, industry-leading freight-matching platform powered by AI and machine learning, recently announced securing a Request…
-
MissionIRNewsBreaks – Safety Shot Inc. (NASDAQ: SHOT) to Serve as Official Title Sponsor of ‘A Special Private Evening with Luke Bryan’
Safety Shot (NASDAQ: SHOT) today announced that it is the official title sponsor of Save Our Musicians event, “A Special Private Evening with Luke Bryan.” At the charity concert event taking place on Nov. 18,…
-
Diamond Lake Minerals Inc. (DLMI) Represents an Attractive Option For Those Looking To Enter The World of Digital Assets
Digital assets are any valuable digital or virtual item, including cryptocurrency, digital tokens, non-fungible tokens (“NFTs”), and more, created, stored, and traded on a digital platform like blockchain. These digital assets are bought, sold, and…
-
Lexaria Bioscience Corp. (NASDAQ: LEXX) Exploring Patented DehydraTECH(TM) Technology’s Effectiveness on GLP-1 Drugs for Potential Diabetes Treatment and Weight Loss
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced plans to launch new human and animal studies that seek to examine its patented DehydraTECH(TM) technology’s potential on GLP-1 drugs for the…
-
MissionIRNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Phase 2 Study Results Published in Peer-Reviewed Journal
PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, is reporting that its phase 2 study research exploring the potential of low-dose suramin intravenous infusions as an autism spectrum disorder (“ASD”)…
-
MissionIRNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) CEO Shares Open Letter to Shareholders
Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is a technology company with a custom-developed Fr8App, an industry-leading freight-matching platform powered by AI and machine-learning offering a real-time portal for B2B cross-border shipping and domestic shipping within the…
-
MissionIRNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces Q3 2023 Financial Results, Operating Highlights
Clene (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., today released its third quarter 2023 financial results and provided recent operating highlights for its ALS clinical program. Among…
Search Articles
Latest Articles
- Silvercorp Metals, Inc. (NYSE-A/TSX: SVM) Reports Solid Production and Revenue in Q1 FY2026
- Clene Inc. (NASDAQ: CLNN) Reports Q2 2025 Results as Company Prepares for NDA Submission and Extends Runway into 2026
- Massimo Group (NASDAQ: MAMO) Accelerates Golf Cart Market Reach with Vietnam Partnership
- Wearable Devices Ltd. (NASDAQ: WLDS): Why Neural Input Technology Is Redefining Human-Computer Interaction
- MissionIRNewsBreaks – FAVO Capital (OTC: FAVO) President Shaun Quin Joins Forbes Business Council